#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peripheral T-cell lymphoma unspecified Lennox-Gastaut syndrome Pancreatic carcinoma metastatic Transferrin decreased Congenital generalised lipodystrophy Spinal muscular atrophy Congenital aplastic anaemia Haemophagocytic lymphohistiocytosis Friedreich's ataxia Inflammatory myofibroblastic tumour Short-bowel syndrome Heritable pulmonary arterial hypertension Malignant neoplasm of choroid Iron overload Paraneoplastic neurological syndrome More trials…

    Learn about Rare Diseases

    Primary biliary cholangitis – Trials in Disease Ocular melanoma – Diagnostics Amyotrophic lateral sclerosis Mucopolysaccharidosis I Haemophilia B without inhibitors Hepatoblastoma – Treatment Thrombotic thrombocytopenic purpura Behcet’s syndrome Retinitis pigmentosa – Diagnostics Marginal zone lymphoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Goserelin Acetate ANTI-GD2-800CW Doravirine HYDROMORPHONE HYDROCHLORIDE Prx005 TETRODOTOXIN Camizestrant Diclofenac Diethylamine Iptacopan L-Tyrosine Atrasentan Hydrochloride Magnesium Chloride Apixaban Encorafenib Ontasameran Bictegravir Sar444656 Bexotegrast Dorocubicel VISUGROMAB More therapies…

    Learn about Your Condition

    Staphylococcal infection Bacterial vaginosis Haemoglobinuria Epicondylitis Cerebral palsy Thalassaemia Chronic fatigue syndrome Vascular malformation Toxic epidermal necrolysis Escherichia infection Bronchopulmonary dysplasia Rectal adenocarcinoma Breast cancer stage III Pathogen resistance Joint stabilisation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study Comparing [18F]meta-fluorobenzylguanidine PET-CT and Iodine (123I) Iobenguane Scans for Detecting Neuroblastoma in Patients

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • Iodine (123I) Iobenguane
    • [18F]Meta-Fluorobenzylguanidine
    The Netherlands

  • Study of Selinexor, Dexamethasone, and Bortezomib for Patients with Refractory Multiple Myeloma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Olanzapine
    • Bortezomib
    • Dexamethasone
    Greece

  • Study on Vitamin D (Colecalciferol) to Increase Free Testosterone in Men with Type 2 Diabetes and Low Testosterone Levels

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Colecalciferol
    Belgium

  • Study on Arbaclofen for Improving Social Function in Children and Adolescents with Autism Spectrum Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    • Arbaclofen
    France Spain

  • Study on Infertility Treatment with Follitropin Alfa and Lutropin Alfa for Women Over 35 with Low Ovarian Response

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Follitropin Alfa
    • Lutropin Alfa
    • Cetrorelix
    Spain

  • Study on Capecitabine and Cyclophosphamide for Patients with Large Pseudomyxoma Peritonei Preparing for Surgery and Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pseudomyxoma peritonei
    Investigated Drugs:
    • Cyclophosphamide Monohydrate
    • Capecitabine
    Italy
Previous Page
1 … 378 379 380 381 382 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!